·
Sopan Pharmaceuticals to Open IPO from Baisakh 2, Over 3.47 Million Shares for General Public
Author
NEPSE TRADING
Kathmandu — Sopan Pharmaceuticals Limited is set to launch its Initial Public Offering (IPO) for the general public starting from Baisakh 2, marking the second phase of its share issuance. The company has completed the allocation of shares reserved for Nepali workers abroad and is now opening the remaining portion to public investors.In this phase, the company will issue 3,474,900 units of shares at a face value of NPR 100 each, amounting to NPR 347.49 million. The offering represents a significant opportunity for retail investors to participate in the pharmaceutical sector.Sopan Pharmaceuticals has received approval to issue a total of 4.29 million shares, which is 25 percent of its issued capital of NPR 1.716 billion. Out of the total shares, 429,000 units were allocated to Nepali workers abroad, 171,600 units to company employees, and 214,500 units to mutual funds. The remaining shares are now being offered to the general public.Investors can apply for a minimum of 10 shares and a maximum of 11,000 shares. The application period will remain open until Baisakh 6, with a provision to extend the deadline until Baisakh 16 if the issue is not fully subscribed within the initial period.NMB Capital Limited has been appointed as the issue and sales manager. Investors can apply through ASBA member banks and financial institutions using the C-ASBA system or via the Mero Share online platform.In terms of credit rating, CARE Ratings Nepal has assigned the company a ‘CARE-NP Single B’ issuer rating, indicating a relatively high risk in meeting its financial obligations. This suggests that while the company may offer growth potential, it carries a higher level of investment risk.According to the company, the payback period for the investment is estimated at 8.11 years, extending to 11.35 years when discounted. The internal rate of return (IRR) stands at 23.63 percent, while the net present value (NPV) is reported to exceed NPR 15.97 billion.
